Kim Dong 4/A
4/A · UroGen Pharma Ltd. · Filed Feb 12, 2024
Insider Transaction Report
Form 4/AAmended
Kim Dong
Chief Financial Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2024-01-31+3,333→ 35,253 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]This amendment corrects and restates the Amount of Securities Beneficially Owned Following Reported Transaction reported in the original Form 4 filed on February 2, 2024.